- 13 May 2014: WHO Technical Consultation on Innovative Models for New Antibiotics’ Development and Preservation
- TDR and the Pooled Fund for R&D: WHO demonstration projects and CEWG follow-up
- OMB's Revised Guidance on Appointment of Lobbyists to Federal Advisory Committees, Boards, and Commissions
- Gilead's US patient access programs for Sovaldi
- Some recent cancer drug prices
- January 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer
- Money speaks: USTR releases letters from Congress backing PhRMA on exclusive rights biologic test data in TPP
- Gilead's MPP license for tenofovir alafenamide (TAF) patents
- Hepatitis research and development timeline
- WIPO General Assembly 2014: Hard Decisions on the Design Law Treaty and Treaty for Protection of Genetic Resources
US government urges WHO to support Medicines Patent Pool: Extract of US intervention on draft WHO HIV/AIDS strategy 2011–2015Submitted by thiru on 18. January 2011 - 12:53
On Tuesday's discussion at the 128th Executive Board on the Draft WHO HIV/AIDS strategy 2011–2015, the United States made a strong intervention (delivered by Dr. Nils Daulaire, Director, Office of Global Health Affairs, Department of Health and Human Services) in support of the Medicines Patent Pool drawing attention to the fact that the draft HIV/AIDS strategy while making reference to a more competitive market for ARVs, failed to recognized the importance of the Medicines Patent Pool.
Here below are the remarks of the US on this point:
Conflicts of Interest, and the WHO evaluation of the FRIND and the PDP Plus funding proposals by the CEWGSubmitted by thiru on 18. January 2011 - 11:19
This note provide additional context for those who are just now following the issue of conflicts of interest and the WHO Consultative Expert Working Group (CEWG) on R&D Financing.
The CEWG follows a controversial, flawed and failed effort by an earlier group, the WHO Expert Working Group (EWG) on R&D Financing, to:
At the end of the day on Monday, the 128 WHO Executive Board meeting took the agenda item for creation of a new R&D Financing consultative expert working group (CEWG). (Yesterday's blog on this topic is here)
World Health Organization Executive Board to create new consultative expert working group on R&D FinancingSubmitted by James Love on 17. January 2011 - 8:55
Today the WHO is expected to take up the Report by the Secretariat on "the Establishment of a consultative expert working group on research and development: financing and coordination." (link here).
The following reports the number of Google hits using the search term "gates foundation," with a site:domainname option, on January 7, 2011. The result is a count of the number of web pages (visible to Google) mentioning the Gates Foundation on a particular domain.
For example, the google search site:who.int "gates foundation" identified 5,940 pages on the who.int web site that have the exact phrase, "gates foundation."
Google hits for "health messages embedded in television" 275,000
Motivating Television Viewers to Become Organ Donors
Authors: Lauren Movius, Michael Cody, Grace Huang, Mandy Berkowitz, Susan Morgan
Corresponding Author: Lauren Movius, Annenberg School of Communication, University of Southern California, firstname.lastname@example.org.
On December 14, 2010, Life Technologies Corporation, which among other things owns Ion Torrent, which sells the Ion Personal Genome Machine sequencer, announced seven new medical innovation prizes. The first three prizes are related to improvements in the Ion semiconcudtor sequencing products. Each of the three sequencer prizes is funded at $1 million, and will be awarded to contestants that can achieve the following goals:
- produce twice as much sequence data,
NSF, Gates Foundation policies on sharing data and intellectual property in agricultural basic research grant program (BREAD)Submitted by James Love on 5. January 2011 - 8:30
The US based National Science Foundation (NSF) and the Bill and Melinda Gates Foundation are collaborating on a program called Basic Research to Enable Agricultural Development (BREAD). A May 12, 2010 NSF announcement about the program is available here.
As 2011 unfolds, the following conferences and negotiations are expected to shape the knowledge governance landscape this year at WHO, WIPO and WTO.
World Health Organization
The graph below reports the ratio of deaths to new cases of tuberculosis in 2004, in WHO "regions by income."
The following graph reports the ratio of DALYs to Prevelance for Asthma in 2004, with countries groups in WHO regions by income.
A pdf version of this document is available here.
KEI Research Note 2010:5
December 23, 2010
Differences in ratio of deaths to new cases for 6 cancer types in 14 WHO regions, with reference to income of region
Cancer: Annual deaths compared to new cases in 2004, for 16 types of cancer and 4 World Bank income groupsSubmitted by James Love on 21. December 2010 - 10:21
The following table compares the annual deaths from cancer, to the annual incidence of the disease, broken down by cancer type and income group. The data in the table is annual deaths divided by annual incidence, show as a ratio.
For several types of cancer, there is not much difference in the reported ratios, between different income groups. For other types of cancer, the differences are large, and in favor of patients living in higher income countries. Cancer types with the largest disparities by income include the following:
- Mouth and oropharynx cancers
Ratio of year 2000 breast cancer deaths to new breast cancer patients in Europe, by country and country incomeSubmitted by James Love on 21. December 2010 - 8:37
The following graph presents the year 2000 raw mortality rate of breast cancer patients in 36 European Countries. The graph compares the ratio of breast cancer deaths to the annual incidence of breast cancer, to the per capita incomes in those countries, all based upon year 2000 data.
USTR has issued a request for comments on ACTA. The deadline for submissions is February 15, 2011. The notice gives very little guidance regarding the issues the USTR would like addressed in the comments.
[Billing Code 3190-W1-P]
Office of the United States Trade Representative
Anti-Counterfeiting Trade Agreement: Request for Comments from the Public
Agency: Office of the United States Trade Representative
Action: Request for written submissions from the public